The flavonoids market is anticipated to expand at a CAGR of 5.6% by 2032 when sales are projected to reach US$ 2.2 billion. It is frequently incorporated into supplements, tablets, and capsules in the pharmacy and nutraceutical industries. Nearly 80%.3% of the market for polyphenols is expected to be made up of flavonoid sales. Flavonoids can be …